Debt to EBITDA ratio Analysis of Verona Pharma PLC - Deep Dive
WARN : Please note that some of the values may not be in base currency

Debt to EBITDA of VRNA
Dec-23
-1.02
Very Poor Debt to EBITDA
Dec-22
-0.0002
Very Poor Debt to EBITDA
Growth
-665024.33
%
Debt to EBITDA Analysis of Verona Pharma PLC
Debt to EBITDA Ratio of VRNA drastically fell by -665024.33 % this year.
Debt to EBITDA Ratio with value of -0.0002 was highest in Year Dec-22 in last Five Years.
Debt to EBITDA Ratio with value of -1.02 was lowest in Year Dec-23 in last Five Years.
Latest Debt to EBITDA Ratio with value of -1.02 is lower than Average Debt to EBITDA of -0.244 in last five years.
Other Debt to EBITDA Related Info of VRNA that may interest you.
Verona Pharma PLC Overview
CodePricePrevious PricePrice ChangeSector
VRNA12.0711.48 5.14 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization.    more ..
Debt to EBITDA Formula

Debt to EBITDA Related Ratios
CashFlowFromOperationToDebtDebtToCapitalEVToEBITDA

Tsr Stability Index
Low Stability Stock
FY - Historical Debt to EBITDA of Verona Pharma PLC
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Debt to EBITDA-1.02-0.0002-0.101-0.084-0.01180229.78
Change-665024.33 %99.85 %-19.73 %-613.19 %-340749.17 %-100.00 %
You are view first 7 Records. Log in to view all 19 in Premium view
FY Chart of Debt to EBITDA of Verona Pharma PLC


Note : All Data Generated at the End of Trading Hours (EOD Data)